MedTrace Logo

Efficacy and Safety of Tiradentes Association in the Treatment of Acute Pain

NCT04593329 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2023-09-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of Tiradentes association in adolescents and adults with acute pain.

Conditions

  • Acute Pain

Interventions

DRUG

TIRADENTES ASSOCIATION

Tiradentes association tablet

DRUG

DIPYRONE

Dipyrone 500 mg

DRUG

TRAMADOL

Tramadol 50 mg

OTHER

TIRADENTES ASSOCIATION PLACEBO

Tiradentes association placebo tablet

OTHER

DIPYRONE PLACEBO

Dipyrone placebo tablet

OTHER

TRAMADOL PLACEBO

Tramadol placebo capsule

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-31
Primary Completion
2023-08-31
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04593329 on ClinicalTrials.gov